Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease

Last updated: May 21, 2025
Sponsor: Stanford University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Moyamoya Syndrome

Treatment

Standard of Care

Clinical Study ID

NCT06880341
77828
  • Ages > 3
  • All Genders

Study Summary

The goal of this study is to study the incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales, binned by week. Collect data on all interventions and assessments performed during the recovery post surgery up to 30 days, to understand what factors might cause Transient Neurologic Events (TNEs) and determine how these can be reduced in Moyamoya subjects post surgery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Moyamoya Disease (MMD) patients undergoing direct extracranial-intracranial (ECIC)bypass. Patients above the age of 3 years old are eligible for the study

Exclusion

Exclusion Criteria:

  • Renal dysfunction, electrolyte disturbances neuromuscular disorders includingMyaesthenia Gravis, heart block

Study Design

Total Participants: 88
Treatment Group(s): 1
Primary Treatment: Standard of Care
Phase:
Study Start date:
May 21, 2025
Estimated Completion Date:
March 31, 2027

Connect with a study center

  • Stanford University Hospital

    Palo Alto, California 94305
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.